Feedback requested: Differentiating HyperHEP B Products

Hi everyone,

We did not receive feedback on the proposed nomenclature, so we will proceed with what is stated here.

Thank you,
Taylor

Hi everyone,

As discussed on the PHSC meeting on Thursday, October 5th, we are seeking feedback from the community regarding the CVC public picklist and clinician picklist terms for the HyperHEP B and HyperHEP S/D vaccines. Specifically, these vaccines are:

45881000087100 |HyperHEP B 110 international units per 0.5 milliliter solution for injection Grifols Canada Limited (real clinical drug)|
SNOMED-CT Preferred Term: HBIg HyperHEP B 110 IU/0.5 mL Grif
Proposed CVC Public Picklist Term: HyperHEP B 110 IU/0.5 mL
Proposed CVC Clinician Picklist Term: HyperHEP B 110 IU/0.5 mL (HBIg)

45871000087102 |HyperHEP B 220 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug)|
SNOMED-CT Preferred Term: HBIg HyperHEP B 220 IU/mL Grif
Proposed CVC Public Picklist Term: HyperHEP B 220 IU/mL
Proposed CVC Clinician Picklist Term: HyperHEP B 220 IU/mL (HBIg)

28411000087101 |HyperHEP B S/D 220 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug)|
SNOMED-CT Preferred Term: HBIg HyperHEP B S/D 220 IU/mL Grif
Proposed CVC Public Picklist Term: HyperHEP B S/D
Proposed CVC Clinician Picklist Term: HyperHEP B S/D (HBIg)

If stakeholders have feedback on the above, we kindly ask that you let us know by end of day, Thursday, October 12th.

Thank you,
Taylor